Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
160 participants
INTERVENTIONAL
2025-12-15
2030-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remote Fentanyl Test Strip Distribution and Education to Prevent Drug Overdose
NCT07128485
Low-dose Buprenorphine Initiation for Opioid Use Disorder
NCT05450718
Evaluating an Intervention to Prevent Overdoses in Rural and Urban Counties
NCT05463341
Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments
NCT03821103
Naltrexone for Overdose Prevention
NCT06633900
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BSAFE Counseling Intervention
The BSAFE intervention will consist of three elements: motivational interviewing-based Counseling focused on a personalized plan to reduce risk for UFU and resultant overdose, (2) weekly text message Safety Reminders, and (3) Linkage to Care for managing stimulant use. The brief counseling intervention will utilize Motivational Interviewing and skills-building techniques to modify personal overdose risk behaviors.
BSAFE Intervention
The intervention will include counseling sessions, reminder safety text messages, and linkage to care.
Attention Control
Participants will watch 45 minute videos unrelated to the intervention as an attention control.
Attention control
Attention control (videos)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BSAFE Intervention
The intervention will include counseling sessions, reminder safety text messages, and linkage to care.
Attention control
Attention control (videos)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Reports intentional cocaine or methamphetamine use \>15 of past 30 days,
3. Urine positive for cocaine or methamphetamine and negative for opioids/fentanyl prior to enrollment
4. Be able to provide the names of at least 2 persons who can consistently locate their whereabouts.
Exclusion Criteria
2. Intends to leave area in coming year,
3. Unable to communicate in English or Spanish,
4. Any other condition that, in the PI's judgment, interferes with safe study participation or adherence to study procedures.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
San Francisco Department of Public Health
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Phillip Coffin, MD, MIA
Director, Substance Use Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Phillip O Coffin, MD, MIA
Role: PRINCIPAL_INVESTIGATOR
San Francisco Department of Public Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
San Francisco Department of Public Health
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.